Replies to post #347011 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

https://www.sec.gov/Archives/edgar/data/1355250/000121390021008496/ea135337-sc13gkipsbay_inn.htm

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:



? Rule 13d-1(b)


? Rule 13d-1(c)


? Rule 13d-1(d)

(c) A person who would otherwise be obligated under paragraph (a) of this section to
file a statement on Schedule 13D (§ 240.13d-101) may, in lieu thereof, file with the Commission, within 10 days after an acquisition described in paragraph (a) of this section, a short-form statement on Schedule 13G (§ 240.13d-102). Provided, That the person:

(1) Has not acquired the securities with any purpose, or with the effect, of changing or influencing the control of the issuer, or in connection with or as a participant in any transaction having that purpose or effect, including any transaction subject to § 240.13d-3(b), other than activities solely in connection with a nomination under § 240.14a-11;

What a link looks like:
https://www.law.cornell.edu/cfr/text/17/240.13d-1
17 CFR § 240.13d-1 - Filing of Schedules 13D and 13G.